Gujarat Themis obtains private credit funding for MicroBiopharm Japan purchase
Bloomberg reports the Indian drugmaker obtained the funding to back its purchase of the Japanese company, highlighting private credit’s growing use for overseas expansion in Asia.
TLDR
Bloomberg reports that Gujarat Themis Biosyn obtained private credit funding to back its purchase of MicroBiopharm Japan. The outlet says the financing highlights the growing use of such debt for overseas expansion in Asia.
Combined views
22.9K
1 Source, first seen 3h ago
54 likes